The takeaway
Globus Medical shows a pronounced seasonal pattern over 10 years of data — strongest in November (+8.3%) and softest in September (−2.8%).
Right now
In July, the stock has risen 60% of years, averaging +0.3%, roughly 1.8 pts behind the S&P 500.
The full picture
Globus Medical's most dependable month has been November, higher in 6 of 10 years; September has been its least reliable, up just 30% of the time.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Win rate % | ||||||||||||
| Median return % | ||||||||||||
| 2025 | ||||||||||||
| 2024 | ||||||||||||
| 2023 | ||||||||||||
| 2022 | ||||||||||||
| 2021 | ||||||||||||
| 2020 | ||||||||||||
| 2019 | ||||||||||||
| 2018 | ||||||||||||
| 2017 | ||||||||||||
| 2016 |
Month by month
The stock's clearest edge over the S&P 500 lands in November (+6.0 pts); it has trailed the market most in September (−2.7 pts).
“vs S&P” is Globus Medical’s average for a month minus the S&P 500’s average for that same month — isolating Globus Medical’s own seasonal edge from broad market drift.
Reality check
Over the last 5 years, November has closed higher 60% of the time versus 60% across the last 10 years — the pattern is holding.
Figures are the typical (median) November return and how often it rose — the last 5 years versus the last 10(the heatmap’s default window). This verdict stays anchored to that 10-year window even if you zoom the chart, so it never disagrees with the badges above.
In plain English
No single month dominates — the stock carries a broad upward tilt, with 9 months rising more often than they fall and November (6 of 10 Novembers) nominally in front.
Its average (+8.3%) and median (+9.0%) land within a hair of each other — the tell of steady, year-after-year gains rather than one outlier doing the work. That reliability comes with real swings, mind — even November ranges by 17.9% from year to year, so any single year can land far from the average. Crucially, the gain is the stock's own rather than a rising tide's: November has cleared the S&P 500 by +6.0 points above the index. Some of that is a strong month market-wide, mind — November rises for about 62% of stocks — so the tendency is real if not unique.
The strength clusters rather than stands alone — October–December forms a firm stretch that carries much of the year. At the other end of the calendar, September has been the soft spot — the weakest of 4 months that average a loss (−2.8%), and the edge isn't year-round — the stock has trailed the S&P 500 in September, February, and March. Its roughest month on record was a −24.3% February in 2023 — a reminder of how hard even a seasonal name can fall.
Reassuringly, the tendency has held its shape: the recent five years still track the years behind them.
Treat it as a tendency rather than a rule — seasonality describes the past, not a promise.
Short answers on the stock's best month (November), its worst (September), and whether it really trades seasonally.
Yes, to a pronounced degree. Since 2016 its best month (November, +8.3%) has run well ahead of its worst (September, −2.8%) — the heatmap above shows how steady that gap has been year to year.
November has been the strongest, averaging +8.3% and closing higher in 6 of 10 years since 2016.
It's the weakest, averaging −2.8% — historically a soft spot, though it still varies from year to year.
Explore
These names have the strongest July track records on record — a starting point for comparison.
Before you trade